Mild to Moderate Acute Respiratory Distress Syndrome
1 clinical trials · Condition
◉ Watch Mild to Moderate Acute Respiratory Distress Syndrome
| Record | Firm | Date |
|---|---|---|
| Post-Market Study of Low-flow ECCO2R Using PrismaLung+ (NCT04617093) | Vantive Health LLC | 2021-04-30 |
Track Mild to Moderate Acute Respiratory Distress Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.